deriving value from your pharma take-back program leo raudys vice president, program development

7
Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Upload: rhoda-barton

Post on 13-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Deriving Value from Your Pharma Take-Back

ProgramLeo Raudys

Vice President, Program Development

Page 2: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Pharmaceutical Take-back… What Does the Landscape Look Like?

Product stewardship is on the rise across multiple industries from batteries to electronics, to unused medicines

Recent local government rulings are requiring prescription drug manufacturers that sell drugs to fund take-back programs

New DEA regulations support this trend

The pharmaceutical industry is facing similar challenges that battery and electronics manufacturers have faced for the past two decades.

Page 3: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Pharmaceutical Take-back Challenges

Regulatory Challenges

New DEA regulation

State pharmacy boards

Household hazardous waste management

Reverse logistics

Program Challenges

Operational complexity

Uncertain cost structures

Page 4: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Collection sites set up at local pharmacies and law enforcement sites

Collections projected at 77,400 pounds by the end of 2016 in King County

Adds foot traffic to retail collection sites

User-friendly and safe receptacles for confidential drop-offs

Strengthened community relations for collection sites

Pharmaceutical Take Back Benefits

Page 5: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Core Competencies for a Successful Take-back Program

Deep knowledge of regulatory safety and compliance and complex processes

Robust collection network and collaborative approach to achieve greater accessibility

Positively managing stakeholder relationships

Highly cost effective and directed public communications

Page 6: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Future Growth

County ordinances

Replicability

Scale will drive costs down

King County

Alameda County

Page 7: Deriving Value from Your Pharma Take-Back Program Leo Raudys Vice President, Program Development

Questions

Leo [email protected]